Annual SGA
$109.28 M
+$10.28 M+10.38%
December 31, 2022
Summary
- As of February 10, 2025, RETA annual SGA is $109.28 million, with the most recent change of +$10.28 million (+10.38%) on December 31, 2022.
- During the last 3 years, RETA annual SGA has risen by +$50.98 million (+87.45%).
Performance
RETA SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly SGA
$45.69 M
-$9.20 M-16.75%
June 30, 2023
Summary
- As of February 10, 2025, RETA quarterly SGA is $45.69 million, with the most recent change of -$9.20 million (-16.75%) on June 30, 2023.
- Over the past year, RETA quarterly SGA has increased by +$20.55 million (+81.72%).
Performance
RETA Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM SGA
-$6.22 B
-$87.62 M-1.43%
June 30, 2023
Summary
- As of February 10, 2025, RETA TTM SGA is -$6.22 billion, with the most recent change of -$87.62 million (-1.43%) on June 30, 2023.
- Over the past year, RETA TTM SGA has dropped by -$6.33 billion (-5955.99%).
Performance
RETA TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
RETA Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10.4% | +81.7% | -5956.0% |
| 3 y3 years | +87.5% | +175.2% | -8517.3% |
| 5 y5 years | +369.8% | +327.4% | -10000.0% |
RETA Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | -9.4% | -16.8% | -45.6% | +36.8% | at low |
| 5 y | 5-year | at high | -46.7% | -16.8% | -63.7% | +187.2% | at low |
| alltime | all time | at high | -89.5% | -16.8% | -93.8% | +2109.6% | at low |
Reata Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | $45.69 M(-16.8%) | $159.87 M(+14.7%) |
| Mar 2023 | - | $54.88 M(+71.4%) | $139.32 M(+27.5%) |
| Dec 2022 | $109.28 M(+10.4%) | $32.02 M(+17.4%) | $109.28 M(+1.4%) |
| Sep 2022 | - | $27.27 M(+8.5%) | $107.82 M(+1.4%) |
| Jun 2022 | - | $25.14 M(+1.2%) | $106.28 M(+3.0%) |
| Mar 2022 | - | $24.84 M(-18.7%) | $103.14 M(+4.2%) |
| Dec 2021 | $99.00 M(+31.8%) | $30.56 M(+18.8%) | $99.00 M(+12.7%) |
| Sep 2021 | - | $25.74 M(+17.0%) | $87.86 M(+9.2%) |
| Jun 2021 | - | $22.00 M(+6.3%) | $80.44 M(+7.2%) |
| Mar 2021 | - | $20.70 M(+6.6%) | $75.05 M(-0.1%) |
| Dec 2020 | $75.13 M(+28.9%) | $19.43 M(+6.1%) | $75.13 M(-3.6%) |
| Sep 2020 | - | $18.31 M(+10.3%) | $77.97 M(+5.5%) |
| Jun 2020 | - | $16.60 M(-20.1%) | $73.94 M(+7.1%) |
| Mar 2020 | - | $20.79 M(-6.7%) | $69.05 M(+18.4%) |
| Dec 2019 | $58.30 M(+78.0%) | $22.27 M(+55.9%) | $58.30 M(+32.6%) |
| Sep 2019 | - | $14.28 M(+22.0%) | $43.97 M(+18.3%) |
| Jun 2019 | - | $11.71 M(+16.6%) | $37.18 M(+2.8%) |
| Mar 2019 | - | $10.04 M(+26.3%) | $36.16 M(+10.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $32.75 M(+40.8%) | $7.95 M(+6.1%) | $32.75 M(+6.5%) |
| Sep 2018 | - | $7.49 M(-30.0%) | $30.75 M(+4.5%) |
| Jun 2018 | - | $10.69 M(+61.3%) | $29.42 M(+19.0%) |
| Mar 2018 | - | $6.63 M(+11.4%) | $24.72 M(+6.3%) |
| Dec 2017 | $23.26 M(+40.1%) | $5.95 M(-3.3%) | $23.26 M(+5.1%) |
| Sep 2017 | - | $6.15 M(+2.7%) | $22.13 M(+10.5%) |
| Jun 2017 | - | $5.99 M(+15.8%) | $20.02 M(+7.8%) |
| Mar 2017 | - | $5.17 M(+7.3%) | $18.57 M(+11.8%) |
| Dec 2016 | $16.60 M(+21.3%) | $4.82 M(+19.3%) | $16.60 M(+2.0%) |
| Sep 2016 | - | $4.04 M(-11.0%) | $16.27 M(+7.0%) |
| Jun 2016 | - | $4.54 M(+41.5%) | $15.21 M(+8.3%) |
| Mar 2016 | - | $3.21 M(-28.6%) | $14.05 M(+2.6%) |
| Dec 2015 | $13.69 M(+18.9%) | $4.49 M(+50.7%) | $13.69 M(+8.1%) |
| Sep 2015 | - | $2.98 M(-11.5%) | $12.67 M(+30.7%) |
| Jun 2015 | - | $3.37 M(+18.0%) | $9.69 M(+53.3%) |
| Mar 2015 | - | $2.85 M(-17.7%) | $6.32 M(+82.3%) |
| Dec 2014 | $11.51 M(-14.1%) | $3.47 M | $3.47 M |
| Dec 2013 | $13.40 M | - | - |
FAQ
- What is Reata Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Reata Pharmaceuticals?
- What is Reata Pharmaceuticals annual SGA year-on-year change?
- What is Reata Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Reata Pharmaceuticals?
- What is Reata Pharmaceuticals quarterly SGA year-on-year change?
- What is Reata Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Reata Pharmaceuticals?
- What is Reata Pharmaceuticals TTM SGA year-on-year change?
What is Reata Pharmaceuticals annual SGA?
The current annual SGA of RETA is $109.28 M
What is the all time high annual SGA for Reata Pharmaceuticals?
Reata Pharmaceuticals all-time high annual SGA is $109.28 M
What is Reata Pharmaceuticals annual SGA year-on-year change?
Over the past year, RETA annual SGA has changed by +$10.28 M (+10.38%)
What is Reata Pharmaceuticals quarterly SGA?
The current quarterly SGA of RETA is $45.69 M
What is the all time high quarterly SGA for Reata Pharmaceuticals?
Reata Pharmaceuticals all-time high quarterly SGA is $54.88 M
What is Reata Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, RETA quarterly SGA has changed by +$20.55 M (+81.72%)
What is Reata Pharmaceuticals TTM SGA?
The current TTM SGA of RETA is -$6.22 B
What is the all time high TTM SGA for Reata Pharmaceuticals?
Reata Pharmaceuticals all-time high TTM SGA is -$281.68 M
What is Reata Pharmaceuticals TTM SGA year-on-year change?
Over the past year, RETA TTM SGA has changed by -$6.33 B (-5955.99%)